Steinen, Germany

Thomas Allmendinger


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas Allmendinger: Innovator in Chemical Compounds

Introduction

Thomas Allmendinger is a notable inventor based in Steinen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of innovative chemical compounds. With a total of 2 patents to his name, Allmendinger continues to push the boundaries of scientific research and application.

Latest Patents

Allmendinger's latest patents include the development of substituted .alpha.-pyrones. These compounds are characterized by a specific formula where R.sup.1 can be --CF.sub.3 or --COOR.sup.3, and R.sup.3 represents the radical of a C.sub.1 -C.sub.18 alcohol diminished by a hydroxyl group. Additionally, R.sup.2 can take on various forms, including halogens and alkyl groups, making these compounds suitable for the preparation of naphtho-1,4-quinones and anthra-1,4-quinones. Another significant patent involves N-fluorinated sulfonamides, which serve as effective fluorinating agents, particularly in stereospecific applications.

Career Highlights

Allmendinger is associated with Ciba-Geigy Corporation, a company known for its advancements in chemical and pharmaceutical products. His work has contributed to the development of innovative solutions in the chemical industry, showcasing his expertise and dedication to research.

Collaborations

Throughout his career, Allmendinger has collaborated with notable colleagues, including Vratislav Kvita and Marcus Baumann. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Thomas Allmendinger stands out as a prominent inventor in the field of chemistry, with a focus on developing advanced chemical compounds. His contributions continue to influence the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…